A defect of CD4+CD25+ regulatory T cells in inducing interleukin-10 production from CD4+ T cells under CD46 costimulation in asthma patients
- PMID: 20528588
- DOI: 10.3109/02770903.2010.481340
A defect of CD4+CD25+ regulatory T cells in inducing interleukin-10 production from CD4+ T cells under CD46 costimulation in asthma patients
Abstract
Background: The suppressive cytokine interleukin-10 (IL-10) plays a central role in disease control and clinical therapies of asthma. CD46 was recently identified as costimulatory molecule in inducing IL-10-producing regulatory T cells type 1 (Tr1) from CD4(+) T cells. Alterations in CD46 costimulation pathway were shown to be associated with multiple sclerosis and hemodialysis. In this study, the authors investigated alterations in CD46 costimulatory pathway in asthma.
Methods: CD4(+)CD25(+) regulatory T cells (Tregs) and CD4(+)CD25(-) T cells were isolated from peripheral blood mononuclear cells (PBMCs) of asthma patients (n = 13) and healthy subjects (n = 17). Both subsets of CD4(+) T cells were cultured alone or cocultured at a ratio of 1:10 under stimulation with CD3/CD28 or CD3/CD46, and the production of IL-10 in the supernatants was assessed by enzyme-linked immunosorbent assay (ELISA), the proliferation rates of the cells were determined with thymidine incorporation assay.
Results: Levels of IL-10 in the supernatants were higher in undivided CD4(+) T cells and 1:10 cocultured CD4(+)CD25(+) Tregs/CD4(+)CD25(-) T cells than in CD4(+)CD25(+) Tregs or CD4(+)CD25(-) T cells alone, either under CD46 or under CD28 costimulation, both in healthy controls (n = 9) and in asthma patients (n = 7). Under anti-CD3/CD46 stimulation, IL-10 production in undivided CD4(+) T cells and cocultured T cells from asthma patients was lower than that in healthy controls. When treated with glucocorticoids, IL-10 production in undivided CD4(+) T cells and 1:10 cocultured CD4(+) T cells was not different between asthma patients (n = 6) and healthy controls (n = 8). The proliferation rates and the surface expression of CD46 were not different in T cells from both groups.
Conclusions: This study identified a new functional defect of CD4(+)CD25(+) Tregs in inducing IL-10 production from CD4(+)CD25(-) T cells under CD46 costimulation in asthma patients, which may be involved in the pathogenesis of allergic asthma.
Similar articles
-
Insufficient increment of CD4+CD25+ regulatory T cells after stimulation in vitro with allergen in allergic asthma.Int Arch Allergy Immunol. 2009;148(3):199-210. doi: 10.1159/000161580. Epub 2008 Oct 10. Int Arch Allergy Immunol. 2009. PMID: 18849611
-
Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.Int Immunol. 2007 Mar;19(3):227-37. doi: 10.1093/intimm/dxl139. Epub 2007 Feb 7. Int Immunol. 2007. PMID: 17289657
-
Dysfunction of IL-10-producing type 1 regulatory T cells and CD4(+)CD25(+) regulatory T cells in a mimic model of human multiple sclerosis in Cynomolgus monkeys.Int Immunopharmacol. 2009 May;9(5):599-608. doi: 10.1016/j.intimp.2009.01.034. Epub 2009 Feb 10. Int Immunopharmacol. 2009. PMID: 19539557
-
T-cell stimulation and regulation: with complements from CD46.Immunol Res. 2005;32(1-3):31-43. doi: 10.1385/IR:32:1-3:031. Immunol Res. 2005. PMID: 16106057 Review.
-
T-cell regulation by CD46 and its relevance in multiple sclerosis.Immunology. 2008 Jun;124(2):149-54. doi: 10.1111/j.1365-2567.2008.02821.x. Epub 2008 Apr 2. Immunology. 2008. PMID: 18384356 Free PMC article. Review.
Cited by
-
CD46 splice variant enhances translation of specific mRNAs linked to an aggressive tumor cell phenotype in bladder cancer.Mol Ther Nucleic Acids. 2021 Feb 24;24:140-153. doi: 10.1016/j.omtn.2021.02.019. eCollection 2021 Jun 4. Mol Ther Nucleic Acids. 2021. PMID: 33767911 Free PMC article.
-
Complement's involvement in allergic Th2 immunity: a cross-barrier perspective.J Clin Invest. 2025 May 1;135(9):e188352. doi: 10.1172/JCI188352. eCollection 2025 May 1. J Clin Invest. 2025. PMID: 40309766 Free PMC article. Review.
-
Prostaglandin E2 affects T cell responses through modulation of CD46 expression.J Immunol. 2012 Jun 1;188(11):5303-10. doi: 10.4049/jimmunol.1103090. Epub 2012 Apr 27. J Immunol. 2012. PMID: 22544928 Free PMC article.
-
Complement regulatory protein CD46 promotes bladder cancer metastasis through activation of MMP9.Int J Oncol. 2024 Jul;65(1):71. doi: 10.3892/ijo.2024.5659. Epub 2024 Jun 7. Int J Oncol. 2024. PMID: 38847230 Free PMC article.
-
"Complimenting the Complement": Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma.Front Oncol. 2021 Feb 24;10:627701. doi: 10.3389/fonc.2020.627701. eCollection 2020. Front Oncol. 2021. PMID: 33718121 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials